Floyd A Benko

Title: Innovations by Inventor Floyd A. Benko

Introduction

Floyd A. Benko is an accomplished inventor based in Palmyra, PA, with a remarkable portfolio of six patents. His groundbreaking work focuses on advancements in detection methods related to neoplastic and proliferative diseases, which have profound implications for cancer diagnostics and treatment.

Latest Patents

Among his most notable inventions, two patents stand out for their innovative approaches to cancer detection. The first, titled "Methods for selecting monoclonal antibody therapies using extracellular DNA," addresses the detection of specific extracellular nucleic acids in plasma or serum fractions of blood. This invention is crucial for identifying the presence of tumor-associated DNA, particularly those derived from mutant oncogenes. It offers a rapid DNA extraction process followed by nucleic acid amplification, which aids in monitoring the existence, progression, or clinical status of various types of neoplasms in both humans and animals.

Benko's second significant patent, "Methods for selecting cancer vaccine therapies using extracellular DNA," parallels the first by focusing on the detection of extracellular nucleic acids in blood related to neoplastic diseases. This innovation equally supports early identification and monitoring of cancers, including colorectal, pancreatic, lung, breast, bladder, and ovarian malignancies, facilitating timely interventions.

Career Highlights

Floyd A. Benko has made substantial contributions to his field, notably during his tenure at esteemed institutions like the Penn State Research Foundation and Penn State University. His work has consistently revolved around enhancing cancer diagnostics and treatment strategies through innovative methodologies.

Collaborations

Throughout his career, Benko has collaborated with professionals such as Christopher D. Gocke and Michael S. Kopreski, further extending the scope and impact of his research. These collaborations underscore the importance of teamwork in fostering innovation and refining the complex methodologies he has developed.

Conclusion

Floyd A. Benko stands out as a significant figure in the realm of cancer research, with his patents aiming to revolutionize how neoplastic diseases are diagnosed and treated. His inventive contributions to the detection of tumor-associated DNA not only enhance the understanding of cancer dynamics but also pave the way for more effective therapeutic approaches.